223 related articles for article (PubMed ID: 28260788)
41. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
42. c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.
Geng CD; Vedeckis WV
J Biol Chem; 2005 Dec; 280(52):43264-71. PubMed ID: 16263717
[TBL] [Abstract][Full Text] [Related]
43. Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type.
Seitz V; Hummel M; Anagnostopoulos I; Stein H
Blood; 2001 Apr; 97(8):2401-5. PubMed ID: 11290603
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL).
Nagel S; Ehrentraut S; Tomasch J; Lienenklaus S; Schneider B; Geffers R; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
PLoS One; 2012; 7(7):e40747. PubMed ID: 22848398
[TBL] [Abstract][Full Text] [Related]
45. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
[TBL] [Abstract][Full Text] [Related]
46. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
47. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
Lindley RA; Hall NE
Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
[TBL] [Abstract][Full Text] [Related]
49. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
50. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by LMO1 in Neuroblastoma.
Saeki N; Saito A; Sugaya Y; Amemiya M; Ono H; Komatsuzaki R; Yanagihara K; Sasaki H
Cancer Genomics Proteomics; 2018; 15(3):165-174. PubMed ID: 29695398
[TBL] [Abstract][Full Text] [Related]
51. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract][Full Text] [Related]
52. LIM domain only 1: an oncogenic transcription cofactor contributing to the tumorigenesis of multiple cancer types.
Zhao GF; Du LQ; Zhang L; Jia YC
Chin Med J (Engl); 2021 Apr; 134(9):1017-1030. PubMed ID: 33870932
[TBL] [Abstract][Full Text] [Related]
53. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells.
Jin ZX; Kishi H; Wei XC; Matsuda T; Saito S; Muraguchi A
J Immunol; 2002 Oct; 169(7):3783-92. PubMed ID: 12244173
[TBL] [Abstract][Full Text] [Related]
54. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
55. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
[TBL] [Abstract][Full Text] [Related]
56. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
[TBL] [Abstract][Full Text] [Related]
57. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
58. A central role for a single c-Myb binding site in a thymic locus control region.
Ess KC; Whitaker TL; Cost GJ; Witte DP; Hutton JJ; Aronow BJ
Mol Cell Biol; 1995 Oct; 15(10):5707-15. PubMed ID: 7565722
[TBL] [Abstract][Full Text] [Related]
59. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
[TBL] [Abstract][Full Text] [Related]
60. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas.
Sutherland KD; Visvader JE; Choong DY; Sum EY; Lindeman GJ; Campbell IG
Int J Cancer; 2003 Oct; 107(1):155-8. PubMed ID: 12925972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
